YVONNE L. GREENSTREET, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ALNYLAM PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2025-03-24 Dr. Greenstreet has over 25 years of experience in the biopharmaceutical industry, driving strategy and innovation, bringing transformative medicines to patients, and building successful businesses.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22